Skip to content

Chromosome 17p13 3 Telomeric Duplication Syndrome C2675492

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder from duplication at the end of chromosome 17p, causing developmental and medical challenges that vary by case. Care focuses on individualized symptom management and therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurological)

Autism spectrum disorder

(neurological)

Epilepsy

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Multisystem Surveillance Protocol

Systematic monitoring for growth restriction, facial dysmorphism complications, and associated anomalies including brain malformations and seizures.

monitoring
3

Developmental Physical Therapy

Therapeutic interventions targeting motor delays, muscle tone abnormalities, and promoting functional mobility appropriate to the child's capabilities.

physical_therapy

Additional treatment options

Cognitive and Learning Support Services

Specialized educational interventions addressing intellectual disability, learning challenges, and providing appropriate academic accommodations.

psychological

Seizure Management

Antiepileptic medication therapy when seizures are present, selected based on seizure type and individual patient factors with regular neurological follow-up.

medication

Family Education and Support Program

Comprehensive family education on syndrome characteristics, prognosis, and practical caregiving strategies with connection to parent support networks.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 17p13 3 Telomeric Duplication Syndrome C2675492?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010.

guideline2010
2

Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011.

review2011
3

Wertheim B, Roos E, van Bokhoven H. Clinical and molecular characterization of patients with 17p13.3 microduplications. Mol Syndromol. 2015.

other2015
4

Shaw-Smith C, Redon R, Rickman L, et al. Microarray-based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet. 2004.

review2004

Medication Comparisons

Compare medications used to treat Chromosome 17p13 3 Telomeric Duplication Syndrome C2675492. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy